Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-11-22
1994-09-20
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514191, 514411, 514422, A61K 31445, A61K 3133, A61K 3140
Patent
active
053489667
ABSTRACT:
Administration of FK506 or related macrolide compounds is effective for the treatment of pyoderma and Sezary's syndrome.
REFERENCES:
patent: 3244592 (1966-04-01), Arai
patent: 4212881 (1980-07-01), Sasaki et al.
patent: 4894366 (1990-01-01), Okuhara et al.
patent: 4929611 (1990-05-01), Okukara et al.
Arai et al, J. Antibiotics, vol. 15, pp. 231-232 (1962).
Swindells et al, Can. J. Chem., vol. 56, pp. 2491-2492 (1978).
Findlay et al, Can. J. Chem., vol. 58, pp. 579-590 (1980).
Tanaka et al, J. Am. Chem. Soc., vol. 109, pp. 5031-5033 (1987).
Chem. Abstracts, 106:134814j (1987).
Chem. Abstracts, 107:236308k (1987).
Chem. Abstracts, 108:101198z (1988).
Chem. Abstracts, 109:170104y (1988).
New York Times, Oct. 18, 1989, pp. 1 and B7.
Starzl Thomas E.
Todo Satoru
Cintins Marianne M.
Criares T. J.
Fujisawa Pharmaceutical Co. Ltd.
LandOfFree
Method for treating pyoderma and Sezary's syndrome using FK 506 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating pyoderma and Sezary's syndrome using FK 506 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating pyoderma and Sezary's syndrome using FK 506 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2429895